As of the most recent data, SGMO shows a ROE of -468187.69%. That is below the Healthcare sector average of 20.86%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about 20.86%. Sangamo Therapeutics is at -468187.69%, which is lower that average. That is roughly 2244872.6% below the sector mean. Use the comparison chart on this page to see how SGMO stacks up against individual peers as well.

Check the historical chart to see whether SGMO's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sangamo Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Sangamo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -468187.69%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about 20.86%, while SGMO is at -468187.69%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.